Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Association between auditory P300, psychopathology, and memory function in drug-naïve schizophrenia.

Chang WH, Chen KC, Yang YK, Chen PS, Lu RB, Yeh TL, Wang CS, Lee IH.

Kaohsiung J Med Sci. 2014 Mar;30(3):133-8. doi: 10.1016/j.kjms.2013.10.003. Epub 2013 Dec 3.

2.

Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: a pilot study.

Park EJ, Han SI, Jeon YW.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):674-80. doi: 10.1016/j.pnpbp.2010.03.011. Epub 2010 Mar 19.

PMID:
20304022
3.

[Event-related potentials P₃₀₀ with memory function and psychopathology in first-episode paranoid schizophrenia].

Liu WB, Chen QZ, Yin HM, Zheng LL, Yu SH, Chen YP, Li HC.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011 Nov;40(6):647-52. Chinese.

PMID:
22190526
4.

Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: cross-sectional and retrospective longitudinal studies.

Higashima M, Nagasawa T, Kawasaki Y, Oka T, Sakai N, Tsukada T, Koshino Y.

Schizophr Res. 2003 Feb 1;59(2-3):147-57.

PMID:
12414071
5.

P300 and disability of daily life in schizophrenia.

Iwanami A, Yamashina M, Kazamatsuri H, Kamijima K.

Prog Neuropsychopharmacol Biol Psychiatry. 1999 Apr;23(3):423-30.

PMID:
10378227
6.

[ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].

Asato N, Hirayasu Y, Hiramatsu K, Ohta H.

Seishin Shinkeigaku Zasshi. 1999;101(3):254-76. Japanese.

PMID:
10375977
7.

P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia.

Higashima M, Urata K, Kawasaki Y, Maeda Y, Sakai N, Mizukoshi C, Nagasawa T, Kamiya T, Yamaguchi N, Koshino Y.

Biol Psychiatry. 1998 Jul 15;44(2):115-20.

PMID:
9646893
8.

Correlation of auditory 'oddball' P300 with verbal memory deficits in schizophrenia.

Shajahan PM, O'Carroll RE, Glabus MF, Ebmeier KP, Blackwood DH.

Psychol Med. 1997 May;27(3):579-86.

PMID:
9153678
9.

P300 subcomponents reflect different aspects of psychopathology in schizophrenia.

Frodl-Bauch T, Gallinat J, Meisenzahl EM, Möller HJ, Hegerl U.

Biol Psychiatry. 1999 Jan 1;45(1):116-26.

PMID:
9894583
10.

Reduction in event-related alpha attenuation during performance of an auditory oddball task in schizophrenia.

Higashima M, Tsukada T, Nagasawa T, Oka T, Okamoto T, Okamoto Y, Koshino Y.

Int J Psychophysiol. 2007 Aug;65(2):95-102. Epub 2007 Mar 19.

PMID:
17448555
11.

Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study.

Mathalon DH, Ford JM, Pfefferbaum A.

Biol Psychiatry. 2000 Mar 1;47(5):434-49.

PMID:
10704955
12.

Decreased P300 current source density in drug-naive first episode schizophrenics revealed by high density recording.

Wang J, Tang Y, Li C, Mecklinger A, Xiao Z, Zhang M, Hirayasu Y, Hokama H, Li H.

Int J Psychophysiol. 2010 Mar;75(3):249-57. doi: 10.1016/j.ijpsycho.2009.12.005. Epub 2009 Dec 24.

PMID:
20004691
13.

Abnormalities of auditory event-related potentials in schizophrenia prior to treatment.

Hirayasu Y, Asato N, Ohta H, Hokama H, Arakaki H, Ogura C.

Biol Psychiatry. 1998 Feb 15;43(4):244-53.

PMID:
9513733
14.

Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia.

Wang J, Hirayasu Y, Hokama H, Tanaka S, Kondo T, Zhang M, Xiao Z.

Psychiatry Clin Neurosci. 2005 Apr;59(2):209-14.

15.

Tripartite relationship among P300, clinical features and brain structure in neuroleptic-naive schizophrenia.

Hoshino KY, Takeuchi S, Jodo E, Suzuki Y, Kayama Y, Niwa S.

Psychiatry Clin Neurosci. 2005 Aug;59(4):410-7.

16.

Electrodermal responsivity distinguishes ERP activity and symptom profile in schizophrenia.

Williams LL, Bahramali H, Hemsley DR, Harris AW, Brown K, Gordon E.

Schizophr Res. 2003 Feb 1;59(2-3):115-25.

PMID:
12414068
17.

Source activation of P300 correlates with negative symptom severity in patients with schizophrenia.

Kim DW, Shim M, Kim JI, Im CH, Lee SH.

Brain Topogr. 2014 Mar;27(2):307-17. doi: 10.1007/s10548-013-0306-x. Epub 2013 Jul 30.

PMID:
23897409
18.

Event-related potentials and genetic risk for schizophrenia.

Winterer G, Egan MF, Rädler T, Coppola R, Weinberger DR.

Biol Psychiatry. 2001 Sep 15;50(6):407-17.

PMID:
11566157
19.

Increased rate of P300 latency prolongation with age in drug-naive and first episode schizophrenia.

Wang J, Hirayasu Y, Hiramatsu K, Hokama H, Miyazato H, Ogura C.

Clin Neurophysiol. 2003 Nov;114(11):2029-35.

PMID:
14580600
20.

P300 reduction and prolongation with illness duration in schizophrenia.

Mathalon DH, Ford JM, Rosenbloom M, Pfefferbaum A.

Biol Psychiatry. 2000 Mar 1;47(5):413-27. Erratum in: Biol Psychiatry 2000 Jun 15;47(12):1091.

PMID:
10704953

Supplemental Content

Support Center